Effect of supplementation in treatment of patients with gestational diabetes

Phase 3

• Conditions: Gestational diabetes.; Diabetes mellitus in pregnancy, unspecified; E28.2

• Registration Number: IRCT201701305623N106
• Lead Sponsor: Vice chancellor for research, Ardabil University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 17 December 2019

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 120

Inclusion Criteria

Patients with gestational diabetes
Age range of 18 to 40 years

Exclusion Criteria

Taking omega-3 fatty acids supplements
Insulin therapy
Placenta abruption
Pre-eclampsia
Eclampsia
Hypo and hyperthyroidism
Smokers

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Hs-CRP. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Elisa kit.;Nitric oxide. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Spectrophotometry.